Furthermore, overexpression of GPR19 in mesenchymal-like breast cancer stimulates E-cadherin expression and promotes the epithelial-like phenotype via the MAPK/ERK1/2 pathway [6]. This evidence concerns the gene GPR19 and breast carcinoma.